Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Income towards Parent Company: 2020-2025

Historic Income towards Parent Company for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$45.1 million.

  • Maravai Lifesciences Holdings' Income towards Parent Company rose 73.87% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 33.91%. This contributed to the annual value of -$259.6 million for FY2024, which is 87.62% down from last year.
  • Maravai Lifesciences Holdings' Income towards Parent Company amounted to -$45.1 million in Q3 2025, which was up 35.48% from -$69.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Income towards Parent Company registered a high of $156.7 million during Q2 2022, and its lowest value of -$172.5 million during Q3 2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Income towards Parent Company value was -$45.1 million (recorded in 2025), while the average stood at -$51.4 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first spiked by 9,227.12% in 2021, then plummeted by 1,582.49% in 2024.
  • Maravai Lifesciences Holdings' Income towards Parent Company (Quarterly) stood at $127.1 million in 2021, then slumped by 31.22% to $87.4 million in 2022, then plummeted by 225.80% to -$110.0 million in 2023, then surged by 58.11% to -$46.1 million in 2024, then surged by 73.87% to -$45.1 million in 2025.
  • Its last three reported values are -$45.1 million in Q3 2025, -$69.8 million for Q2 2025, and -$52.9 million during Q1 2025.